BAI, a novel Cdk inhibitor, enhances farnesyltransferase inhibitor LB42708-mediated apoptosis in renal carcinoma cells through the downregulation of Bcl-2 and c-FLIP (L)

Author:                      

Publisher: Spandidos Publications

ISSN: 1019-6439

Source: International Journal of Oncology, Vol.45, Iss.4, 2014-01, pp. : 1680-1690

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content